$OGN SEC Filings

Filed On	Filing
14 Aug 2026	SCHEDULE 13G
12 Aug 2026	Form 4: Arjona Ferreira Juan Camilo, Head of R&D & CMO Received 11,519 shares by exercise or conversion · Gave up 4,134 shares to cover exercise price or tax ($56.3K) · Acquired 11,519 Restricted Stock Units (Option Exercise/Conversion)
05 Aug 2026	144
05 Aug 2026	Form 4: Drinane Juliana Papa, Head of Mfg & Supply Sold 14,761 shares ($200K)
31 Jul 2026	SCHEDULE 13G/A
31 Jul 2026	8-K: Regulation FD Disclosure
31 Jul 2026	10-Q
23 Jul 2026	8-K: Submission of Matters to a Vote of Security Holders
17 Jul 2026	DEFA14A
17 Jul 2026	8-K: Other Events
17 Jun 2026	Merger proxy: special meeting on July 23, 2026
15 Jun 2026	Form 4: Sharp Shalini, Director Granted 17,857.143 Phantom Stock ($240K)
15 Jun 2026	Form 4: Sequeira Ramona, Director Granted 17,857.143 Phantom Stock ($240K)
15 Jun 2026	Form 4: Patton Cynthia M, Director Granted 17,857.143 Phantom Stock ($240K)
15 Jun 2026	Form 4: Ozuah Philip, Director Granted 17,857.143 Phantom Stock ($240K)
15 Jun 2026	Form 4: Leone Deborah R, Director Granted 17,857.143 Phantom Stock ($240K)
15 Jun 2026	Form 4: Lazarus Rochelle B, Director Granted 17,857.143 Phantom Stock ($240K)
15 Jun 2026	Form 4: Gayle Helene D, Director Granted 17,857.143 Phantom Stock ($240K)
15 Jun 2026	Form 4: Ezekowitz Alan, Director Granted 17,857.143 Phantom Stock ($240K)
15 Jun 2026	Form 4: Essner Robert, Director Granted 17,857.143 Phantom Stock ($240K)

Comments